Objectives: To evaluate the use of direct hemoperfusion with polymyxin B-immobilized fiber (PMX-DHP) as adjunctive therapy during pediatric patients with septic shock.
Design: Prospective observational study.
Setting: Nine-bed PICUs at university referral hospital.